A Quick Note On The Election
Insights - Donald Trump has been elected the 45th president of the United States! Between the Trump victory, Republicans maintaining congress, and the failure of California’s Proposition … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
ASH Abstracts Are Out, and They’re Not Helping Biopharma
Research - The NASDAQ Biotech Index Fund (IBB) is down 1.5%, the SPDR S&P Biotech ETF (XBI) down 3% and testing its 200-week moving average and current … Continue Reading
Premium
Earnings Among Biotech Are OK, But The Sector Still Can’t Catch a Bid
Insights - In last week’s webinar, we discussed why the Presidential election has been weighing on the sector. It’s not just a Clinton Victory (which is largely … Continue Reading
Premium
Medical Conferences Loom: PropThink’s October Webinar
Insights - A recording of our October Healthcare Huddle is now available. Unfortunately, SOMEONE forgot to record the actual webinar last night, so we re-recorded it this … Continue Reading
Premium
One Asset, Two Settings
Research - In 2014, Valeant Pharmaceuticals (VRX) divested of its filler and toxin aesthetics assets to Galderma, now part of Nestle, for $1.4 billion. The deal included … Continue Reading
Premium
Depomed is Still on the Auction Block
Research - The buyout rumors around Depomed (DEPO) continue to swirl, with DealReporter on Wednesdaymorning saying that the company is in discussion with suitors. Depomed rebuked Horizon … Continue Reading
Premium
Updates on Some Recent Ideas
Research - Marinus Pharmaceuticals (MRNS) finally released top-line results from their small study of ganaxolone in PCDH19 this morning. Recall we covered this in our August webinar … Continue Reading
Premium